[VRDN] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
27-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -40.29%
YoY- -57.30%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 72 105 214 54 880 476 1,192 -37.34%
PBT -66,860 -45,785 -28,946 -90,742 -10,118 -10,317 -6,386 47.88%
Tax 5,534 -3,281 3 130 50 289 77 103.83%
NP -66,860 -42,504 -28,946 -90,742 -10,118 -10,317 -6,386 47.88%
Tax Rate - - - - - - - -
Total Cost 66,932 42,609 29,160 90,796 10,998 10,793 7,578 43.75%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -92,861.11 -40,480.00 -13,526.17 -168,040.74 -1,149.77 -2,167.44 -535.74 136.03%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -1.35 -1.05 -2.59 -23.07 -4.69 -5.02 -4.30 -17.55%
EPS Diluted -1.35 -1.05 -2.59 -23.07 -4.69 -5.02 -4.30 -17.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.